QSimulate Receives $2.5 Million in a New Funding Round
dougfinke2024-08-27T22:02:58-07:00Quantum Simulation Technologies, Inc. (QSimulate) has secured $2.5M in funding from 2xN, UTokyo IPC, and Kyoto iCAP. The investment will bolster QSimulate’s business, which focuses on its quantum physics-based drug-discovery platform, QSP Life. This platform includes QUELO, QuValent, and QuantumFP, which cover various aspects of drug design. QSimulate employs proprietary quantum physics-based algorithms to predict solutions to large-scale biological problems. Its technology has facilitated the first quantitative application of quantum mechanics to drug design, offering predictions with unparalleled accuracy. This has paved the way for the computational study of new therapeutic classes. In partnership with Google Quantum AI, QSimulate has contributed [...]